SynthesisFrontiers in endocrinology2025
Charting the growth of idiopathic short stature research: a 32-year bibliometric study of global advances.
Synthesis in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Three decades of recombinant human growth hormone research in children born small for gestational age: a bibliometric analysis (1996-2025).Frontiers in pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Idiopathic short stature (ISS) is a common paediatric endocrinological disorder defined by a height > two standard deviations (SDs) below the mean for age, sex, and ethnicity without an identifiable cause. This condition accounts for 60-80% of short stature cases in children and presents with complex and heterogeneous aetiology. ISS-related research has expanded rapidly over the past three decades; however, a comprehensive bibliometric analysis outlining its developmental trajectory and identifying emerging research priorities remains unavailable. Therefore, using network visualisation tools, we mapped 32 years of research to identify key trends, influential contributors, relevant journals, and emerging directions in ISS. Methods: Publications related to ISS in children, published between January 1993 and December 2024, were retrieved from the Web of Science Core Collection. Bibliometric and visual analyses were conducted using CiteSpace 6.1.R6, VOSviewer 1.6.20 and R package Bibliometrix. The analysis examined multiple dimensions, including annual publication trends, country and institutional contributions, collaboration networks, influential authors and journals, keyword evolution, and co-cited references to map the global ISS research landscape. We retrieved clinical trials published between 1993 and 2024 from the PubMed database to analyze the clinical progress in this field. Results: A total of 1, 567 articles were included in the analysis. The volume of publications in the ISS field has steadily increased over time. The United States of America contributed the most publications. Leiden University in the Netherlands produced the highest number of institutional publications. Wit authored the greatest number of publications, whereas Ranke had the highest number of citations. Discussion: This study systematically mapped the developmental trajectory and thematic evolution of ISS research over the past three decades using a comprehensive bibliometric analysis. The findings identified key contributors and research hotspots, providing valuable insights and reference points to guide future investigations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.